Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway
PMID: 38955027
Source: Int Immunopharmacol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL